The Online Investor
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
CVS Buyback image

CVS Caremark Corporation Buyback

OLI recorded this information on 9/19/2012

Company: CVS Caremark Corporation
Buyback: CVS buyback
$Amount Authorized: $6,000,000,000
Buyback Details: CVS Caremark Corporation announced that its Board of Directors has approved a new share repurchase program for up to $6.0 billion of the company's outstanding common stock. The share repurchase authorization, which is effective immediately, permits the company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.

CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.

CVS Health SEC Filing Email Alerts Service

Open the CVS Page at The Online Investor »

Company Name:  CVS Health Corporation
Stock buyback:  CVS buyback
Website:  www.cvshealth.com
Sector:  Diagnostics
Number of ETFs Holding CVS:  105
Total Market Value Held by ETFs:  $12.73B
Total Market Capitalization:  $99.82B
% of Market Cap. Held by ETFs:  12.76%
 

Open the CVS Page at The Online Investor (in a new window) »

March 29, 2024    5:49 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree CVS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.34 out of 4)
50th percentile
(ranked higher than approx. 50% of all stocks covered)

Analysts' Target Price:
CVS Stock Forecast

Based on Zacks ABR data;
powered by Xignite

CVS Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.